Si-Bone (SIBN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

SIBN Si-Bone

Watchlist

13.780
+0.760+5.84%

Trading Dec 4 13:48 ET

577.91MMarket Cap-15142P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Morgan Stanley Initiates Si-Bone(SIBN.US) With Buy Rating, Announces Target Price $15
Moomoo NewsDec 2 08:31 ET · Ratings
SI-Bone Assumed With an Overweight at Morgan Stanley
TipRanksDec 2 07:50 ET
Wall Street Analysts See an 83.56% Upside in Si-Bone (SIBN): Can the Stock Really Move This High?
Zacks Nov 26 09:00 ET
Don't Ignore The Insider Selling In SI-BONE
Simply Wall StNov 23 07:58 ET
SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024
GlobeNewswireNov 20 16:09 ET
Needham Maintains Si-Bone(SIBN.US) With Buy Rating, Maintains Target Price $19
Moomoo NewsNov 20 07:31 ET · Ratings

Comments

Moomoo AI

Feb 24 06:27

The recent insider sale of SI-BONE shares and the absence of insider purchases over the past year might worry investors. The low level of insider ownership and recent selling activity could indicate a misalignment between insiders and other shareholders.

Have Insiders Sold SI-BONE Shares Recently?

Moomoo AI

Jan 9 05:11

SI-BONE's high P/S ratio is justified by its superior revenue growth and future prospects. Shareholders are confident in the company's future revenues, keeping the share price buoyant.

Shareholders Should Be Pleased With SI-BONE, Inc.'s (NASDAQ:SIBN) Price

Moomoo AI

Dec 13, 2023 06:49

Multiple insider stock sales over the past year, including a notable sale at the current price, suggests reduced confidence in the firm's equity. The lack of insider purchases enhances these doubts about prospective share performance. Even with insider ownership, the ongoing sell-off hints at a careful approach to buying the company's stock.

SI-BONE Insiders Sold US$2.8m Of Shares Suggesting Hesitancy

Moomoo AI

Oct 12, 2023 06:55

The company's future could potentially bright despite underperformance, due to revenue growth. However, past unprofitability may have affected investors' sentiment. Note the 3 warning signs for SI-BONE as possible risks.